Receptors on lymphocytes play a crucial role in antigen recognition and effector function during an immune response. In the case of the B cell, this antigen receptor has been conclusively identified as immunoglobulin (1, 2). In contrast, despite intensive investigation, the exact identity of the T cell receptor for antigen remains unknown. Some studies using conventional anti-idiotypic antisera have suggested similarities between T cell receptors and the VH region of immunoglobulin (3, 4), whereas other experiments involving anti-isotypic antisera indicate the presence of to-(5, 6) and ~-like (7, 8) molecules on the surface ofT lymphocytes. However, because all such studies suffer from the difficulties associated with the use of poorly defined conventional antisera, the relationship between classical immunoglobulin and the T cell receptor remains a subject of great controversy.
Myeloma Proteins, Recombined Molecules, Hybridoma Immunoglobulins, and Isolated Heavy and Light
Chains. Column-purified myeloma proteins were a generous gift of R. Coffman and C.
Nottenburg, Stanford University. The hybridoma anti-PC antibodies M2, M3, and G1 were provided by P. Gearhart, Carnegie Institution of Washington; the chain composition of these antibodies has been determined by amino acid sequence analysis (11) . All three hybridomas possess the T15 H chain; M2 has the T15 L chain, M3 has the MePC603 L chain, and G1 has the MOPC167 L chain. Hybridoma anti-PC antibodies representing the two kappa chain markers were a gift of L. Claflin, University of Michigan (12) . The three hybridomas are all of the IgM isotype; 221A4 is from an AKR animal (I~ac-Pca), 991G2 is from a C58 animal (Ig~c-Pc a) and 552D3 is from a BALB/c animal (Iglc-Pe~). The isolated heavy and light chains of TI5 and W3207 and the McPC603 H/T15 L recombined molecules were obtained from A. Goetze, California Institute of Technology (13) . BALB/c immunoglobulin was prepared by 50% ammonium sulfate precipitation from normal serum.
Cell Lines. All cell lines are maintained in culture in our laboratory in RPMI-1640 medium supplemented with 10% fetal calf serum (FCS). The T lymphomas used in this study include: the spontaneous AKR lymphoma KKT-2, the RadLV-induced C57BL/Ka lymphoma VL-3 (obtained from H. Kaplan, Stanford University), the chemical-induced C57BL/6 tumor EL4, and the radiation-induced C57/L lymphoma L691. The non-T tumors used in this study include: the DBA/2 mastocytoma P815, the BALB/c nonprodueer myeloma NS-1, and the Abelson virus-induced pre-B cell tumors L1-2 and RAW112, of C57L and BALB/e origin, respectively. The BW5147 parental line (Thy-1 +) and the Thy-1-mutants, B5147.6.1 and BW5147.3, were obtained from R. Hyman at The Salk Institute, San Diego, Calif. (14) .
Synthetic Labeling of Monoclonal Antibodies.
Hybridoma cell lines were obtained from tissue culture and washed twice in Hanks' balanced salt solution without serum. The cells were resuspended in leucine-free minimum essential medium (MEM) plus 5% dialyzed FCS (MEM- 6 3 3 5) and adjusted to 3 × 10/ml. 5/~Ci/ml of [ H]leueine was added together with 0.01 ml of 10-M cold leueine to give a final leucine concentration of 10 -5 M. 3 ml of cell solution was plated in petri dishes at 37°C plus 7% CO2. After 5 h incubation, 0.09 ml of complete MEM-5 was added to each plate. After an additional 30 rain, the cell suspension was spun for 6 min at 1,200 rpm to pellet the cells. The supernatant was dialyzed three times against 100× volume of phosphate-buffered saline plus 1 mM sodium azide (PBS-Az), and then clarified by spinning for 10 min at 10,000 rpm.
Myeloma-binding Assays. Solid-phase immunoassays were performed in 96-well flexible microtiter plates (Dynatech Laboratories, Inc., Dynatech Corp., Alexandria, Va.). Wells were coated for 16 h at 4°C with 0.05 ml of a 100/Lg/ml solution of the myeloma ~rotein in PBS-Az. After washing three times with PBS-Az plus 5% FCS (PBS-5), 0.05 ml of [ H]leueine-labeled hybridoma supernate (25,000-50,000 cpm) was added to each well. After incubation for 2 h at 4°C, the wells were again washed three times with PBS-5, cut using a hot wire device, and transferred to scintillation fluid (Biofluor; New England Nuclear, Boston, Mass.) for counting.
Cell-binding Assay. Assays were performed in 96-well microtiter plates. Cell suspensions were prepared in cell suspension medium plus 5% FCS (CSM-5) and adjusted to 2.5 × l0 T cells/ml. 2.5 × 105 cells were added to each well together with 0.04 ml of 3H-labeled monoclonal antibody (25,000-50,000 cpm). After incubation at 4°C for 1 h, the wells were washed three times with PBS-5. The wells were cut using a hot wire and transferred to scintillation fluid for counting. In some assays, unlabeled hybridoma supernatant fluids were used as the first stage rather than the ~H-labeled antibody. In this case, a second-stage ~28I rabbit anti-rat Ig (25,000-50,000 cpm in 0.025 ml) was added to the cells and incubated for 1 h at 4°C. After three washes in PBS-5, the wells were cut with a hot wire and transferred directly to tubes for counting.
Fluorescence-activated Cell Sorter (FACS) Analysis. Cell suspensions of normal lymphoid tissues or tissue culture lines were prepared in CSM-5 at a concentration of 10a/ml. 0.01 ml of cells was added to a conical tube together with 0.04 ml of hybridoma antibody. After incubation for 15 min on ice, the ceils were washed once over an FCS underlayer. The pellet was re.suspended in 0.01 ml of fluorescein isothioeyanate (FITC)-labeled rabbit anti-rat Ig second stage and incubated for 15 min on ice. After a final wash over FCS, the cells were resuspended in 1 ml of PBS-Az for FACS analysis.
Inhibition of Antibody Binding to T15. 0.05 ml ofT15 (100 #g/ml) was added to each well of a microtiter plate and incubated for 16 h at 4°C, and the wells were washed three times with PBS-5. For hapten inhibition of 42-21 binding, a PC-bovine serum albumin (BSA) conjugate was prepared using p-diazonium phenylphosphorylcholine (Biosearch, San Rafael, Calif.) according to the method of Cosenza et al (15) . Various dilutions of PC-BSA were added to the T15-coated wells and incubated for an additional hour. For antibody inhibition of 42-21 binding, 0.05 ml of unlabeled hybridoma supernate was added to each well. In either case, after 1 h at 4°C, the wells were washed three times with PBS-5, and 0.025 ml of 3H-labeled antibody (25,000-50,000 cpm) was added. After an additional 1 h incubation, the plates were again washed, and the wells were cut with a hot wire and transferred to scintillation vials for counting.
Inhibition of Myeloma Binding to 42-21.
In some cases, microtiter plates were coated for 16 h at 4°C with 0.05 ml of purified rabbit anti-rat Ig serum (100 #g/ml) in PBS-Az. The wells were washed three times with PBS-5, and 0.05 ml of hybridoma supernate was added. After incubation for 1 h at 4°C, the wells were washed and then incubated with 0.05 ml of 1% normal mouse serum to block nonspecific binding sites. For specific blocking, dilutions of purified unlabeled hybridoma immunoglobulin were added to the wells for 1 h at 4°C. The wells were again washed and 0.025 ml of 3H-labeled M2 protein (25,000-50,000 cpm) was added to each well for 1 h. After a final wash in PBS-5, the wells were cut and transferred to scintillation fluid for counting.
Antibody Absorption. Cell suspensions for antibody absorptions were prepared by passing normal C57BL/6J mouse tissues through a wire mesh. Labeled monoclonal antibodies to be absorbed were either mixed vol:voi with packed cells, or with a pellet containing a known number of cells. After incubation for 1 h at 4°C, the cells were pelleted again for 6 min at 1,200 rpm. The absorbed supernate was counted directly, or in some cases was tested for residual binding activity on T 15-coated microtiter wells. For antibody absorption with myelomas, T 15 and normal mouse Ig coupled to Sepharose 4B were obtained from R. Coffman. 0.1 ml of labeled antibody was mixed with 0.05 ml of packed Sepharose and incubated for 1 h at 4°C. The Sepharose was removed by pelleting at 1,200 rpm for 6 rain, and the supernate was tested for residual binding to the KKT-2 T cell lymphoma.
Results

Isolation of the 42-21 Monoclonal Antibody.
Fisher rats were immunized against the spontaneous AKR T lymphoma, KKT-2, to produce a series of monoclonal antibodies reactive with normal and neoplastic lymphocytes. From the original hybridization, 100 wells were obtained that produced supernatant fluids reactive with KKT-2 cells. Further screening against purified KKT-2 SL virus resulted in 50 of these, which were found to react with viral structural proteins; these were excluded from this study. All but two of the remaining hybrids were found to react with normal T cells and thymocytes, and thus were candidates for further screening against a panel of purified mouse myeloma proteins representing all immunoglobulin isotypes. In the initial screening, only three hybridoma supernatant fluids bound to any of the myeloma proteins, and all of these showed the same pattern of reactivity: binding to the TI5 myeloma (a, i¢, PC binding), but to no other myeloma in the panel. Of the three T15-binding hybrids, two were lost before subsequent testing was possible. The remaining hybrid, 42-21, was grown to larger volume in flasks and then subcloned by limiting dilution on a thymocyte feeder layer. Of the 15 subclones of 42-21, only one bound to KKT-2 cells; this same clone was also the only one to bind to the T15 myeloma protein.
Characterization of the 42-21 Antigen on the T15 Myeloma. Preliminary evidence on the nature of the 42-21 antigen was obtained by examining the binding of this antibody to a complete panel of purified myeloma proteins (Table I) . Binding was observed for Using a panel of isolated heavy and light chains, recombined molecules and hybridomas, the antigenic site on the T15 molecule was localized further (Table II) . The 42-21 antibody binds to isolated T15 light chains, but not to T15 heavy chains, and selectively interacts with recombined or hybridoma immunoglobulins containing the TI5 light chain. In an inhibition study, the M2 hybridoma (T15 L, TI5 H, as determined by amino acid sequence) was found to inhibit completely the binding of labeled M2 to 42-21, whereas the M3 hybridoma (MOPC603 L, T15 H, by amino acid sequence) had no effect (Fig. 1) . These findings are consistent with the conclusion that 42-21 detects a T15-specific idiotype on the V~ light chain. The 42-21 antigen was not detected on normal immunoglobulin from unimmunized BALB/c mice. In addition, this V, determinant is distinct from the x chain marker described by Claflin (12) , because the 42-21 hybridoma binds equally well to both types of light chains (Table II) .
To test whether the 42-21 antigen is binding-site related, blocking studies were performed with the PC hapten. Antibody binding is only weakly inhibited by high concentrations of free hapten (data not shown), but even trace amounts of a PC-BSA conjugate significantly block 42-21 binding to T15 (Fig. 2) ; 71-11, a monoclonal antibody that recognizes a cross-reactive idiotype present on all PC-binding myelomas, 
* Suspensions of the various ceils were incubated with the indicated antibody, followed by a FITC-labeled rabbit anti-rat Ig second stage. Analysis was performed on a FACS. :1: Relative fluorescence standardized to a scale with 31-11 staining on thymocytes arbitrarily assigned a value of 100. § Cell suspensions were prepared from normal lymphoid tissues of 6-wk-old male C × B/J mice. the 42-21 antigen on T15 as a V~ idiotype, the antibody was investigated for binding to a panel of normal lymphoid cells and tumors (Table III) . The 42-21 antibody binds to all T cell tumors, but not to non-T tumors, and shows a pattern of binding to normal lymphoid cells identical to that of an anti-Thy-1 hybridoma, 31-11 (16) . The reduced median fluorescence on T cells observed with 42-21 when compared with 31-11 is probably related to differences in the ability of the FITC-labeled second stage to react with different rat isotypes (IgM vs. IgG). In addition, staining of frozen lymphoid sections is confined to T-dependent areas (R. Rouse, personal communication). By absorption, the 42-21 antigen is found on all lymphoid tissues, but not on other organs, such as liver (Fig. 3) . Brain tissue was almost as effective as thymus in absorbing out the 42-21 antibody.
Because the Thy-1 antigen is found also on the brain and thymus, well-characterized anti-Thy-1 antibodies were examined for their ability to block the binding of 42-21 to thymocytes (Fig. 4) . The anti-Thy-1 monoclonal, 31-11, blocks 42-21 binding, whereas other monoclonals specific for Lyt-1, Lyt-2, or a cross-reactive PC idiotype (71-11) have no effect. The relationship between the Thy-1 molecule and the 42-21 antigen is supported by several additional independent lines of evidence: (a) the failure of the 42-21 antibody to bind to Thy-1-mutant cell lines (Fig. 5) ; (b) the localization of 42-21 and anti-Thy-1 antibodies to the same cells in the brain, as determined by immunohistochemical analysis on frozen sections (R. Rouse, personal communication); and (c) the precipitation of a 25,000-28,000 mol wt glycoprotein from the surface of labeled T lymphomas and lymphocytes (9) . Thus, the 42-21 antibody appears to recognize the Thy-1 antigen on all T lymphocytes.
Demonstration of the Cross-Reaction between TI5 and Thy-1. Although the 42-21 cell line has been subcloned by limiting dilution, the binding of this antibody to both the T15 myeloma protein and the Thy-1 molecule theoretically could be due to two antibody populations present in the same hybridoma supernate. To rule out this possibility, it was necessary to investigate the ability of one of these antigens to absorb out antibody activity against the other antigen. Absorption of the 42-21 antibody Thymus cells were preincubated with unlabeled blocking antibodies, and then tested in a cell binding assay using °H-labeled 42-21 antibody. with thymocytes removes all activity against the T15 myeloma, whereas similar absorption of another monoelonal antibody recognizing a cross-reactive PC idiotype not present on T cells (71-11) has no effect (Fig. 6) . Similarly, absorption of 42-21 with T15-Sepharose removes binding to thymocytes, whereas normal mouse IgSepharose has no effect (Fig. 7) . Thus, it is evident that the binding of 42-21 to both Thy-1 and T15 represents a true cross-reaction, rather than a contaminating antibody specificity present in the hybridoma supernate.
Discussion In an attempt to identify cell surface molecules on T lymphocytes that cross-react with immunoglobulin, we have isolated a monoclonal antibody that detects an antigenic determinant shared by V,-T15 and the Thy-1 molecule. This unexpected cross-reaction is of interest because it conclusively demonstrates that a unique idiotypic determinant present on a purified immunoglobulin is shared by another normal cellular component present on all T cells. This finding may represent merely a trivial cross-reaction of no structural or functional significance, or it may imply a role for the Thy-1 molecule in antigen and/or mitogen recognition. The Thy-1 molecule has been shown to possess structural homology to an immunoglobulin domain (17) , and highly significant sequence homology to VH and VL regions (A. Williams and J. Gagnon, personal communication). In addition, it has been suggested that the Thy-1 antigen plays a functional role in morphogenetic changes in cultured epithelial cells (18) , in recirculation of mature T cells (19) , and in the in vitro development of myogenic cell lines (20) .
It is interesting to note our own experiments using the 42-21 antibody to block normal and neoplastic T cell growth and function. We have shown that the 42-21 antibody significantly inhibits T cell-mediated allogeneic killing (N. Hollander, E. Pillemer, and I. L. Weissman, manuscript in preparation) and also inhibits virus binding to virus receptors on T lymphoma cells (9) . Both of these phenomena probably represent steric hindrance of antigen or viral receptors, but it is possible that the Thy-1 molecule itself could be linked to T cell receptors as part of a mitogenic apparatus. In addition, we have demonstrated that anti-Thy-1 antibodies block concanavalin A-induced T cell mitogenesis (21) and T lymphoma cell proliferation (9, 16) in vitro. This provides further support for a direct role for the Thy-1 molecule in normal and neoplastic T cell growth control.
The occurrence of the Thy-1 antigen on both T cells and cells of the central nervous system is a particulady intriguing phenomenon. Although the Thy-1 molecule is found on many different cell types in the brain (22) , it has been suggested that it plays a selective role in synaptic transmission. Thus, injection of anti-Thy-1 antibodies into a rat hypothalamus results in selective blockade of cholinergic function (23) . Recently, Fuchs et al. (24) have detected a thymic cell surface antigen using antibodies prepared against purified acetylcholine receptors. Although highly speculative, it is interesting to consider the relationship of these observations to our finding of a crossreactive idiotype on the Thy-1 molecule and the T 15 myeloma, a molecule that binds acetylcholine as well as PC (25) .
As our studies on the 42-21 antigen have demonstrated, serological identity cannot be equated with structural or functional similarity. A similar unexpected crossreactivity between light chains and T cells was found to be due to a determinant on fl-2 microglobulin (26) . Attempts to isolate and characterize the T cell receptor for antigen will continue to rely heavily on detection of immunoglobulin-related molecules on T cells, using antisera prepared against purified immunoglobulin. However, future studies on the T cell receptor must take into account the possibility that such antisera (or even monoclonal antibodies) may recognize a cell surface antigen on all or a subset of T cells shared by a normal component unrelated to classical immunoglobulin.
Summary
To identify T lymphocyte antigens with immunoglobulin-like determinants, we prepared rat anti-mouse T cell monoclonal antibodies and screened them against a panel of purified mouse myeloma proteins representing all isotypes of immunoglobulin. One hybridoma, designated 42-21, was found to detect a novel antigenic determinant shared by V,-TEPC15 and the Thy-1 molecule on all T lymphocytes. Although several explanations for this unusual phenomenon exist, it may imply some role for the Thy-1 molecule in antigen and/or mitogen recognition. In any event, future studies of idiotypes on T lymphocytes must consider the possibility that antiidiotypic sera detect cell surface molecules unrelated to classical immunoglobulin.
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